CME Group Inc (CME) Holdings Increased by Archon Partners LLC
Archon Partners LLC raised its position in shares of CME Group Inc (NASDAQ:CME) by 10.2% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 5,400 shares of the financial services provider’s stock after acquiring an additional 500 shares during the period. Archon Partners LLC’s holdings in CME Group were worth $919,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Edgewood Management LLC increased its stake in shares of CME Group by 2.8% in the second quarter. Edgewood Management LLC now owns 7,840,451 shares of the financial services provider’s stock worth $1,285,207,000 after acquiring an additional 215,439 shares during the last quarter. Janus Henderson Group PLC increased its stake in shares of CME Group by 13.2% in the second quarter. Janus Henderson Group PLC now owns 6,129,157 shares of the financial services provider’s stock worth $1,004,691,000 after acquiring an additional 716,655 shares during the last quarter. Thornburg Investment Management Inc. increased its stake in shares of CME Group by 3.8% in the third quarter. Thornburg Investment Management Inc. now owns 3,614,874 shares of the financial services provider’s stock worth $615,288,000 after acquiring an additional 132,991 shares during the last quarter. Fiera Capital Corp increased its stake in shares of CME Group by 2.8% in the second quarter. Fiera Capital Corp now owns 2,225,333 shares of the financial services provider’s stock worth $364,777,000 after acquiring an additional 60,825 shares during the last quarter. Finally, Standard Life Aberdeen plc increased its stake in shares of CME Group by 38.1% in the second quarter. Standard Life Aberdeen plc now owns 1,765,929 shares of the financial services provider’s stock worth $289,472,000 after acquiring an additional 487,442 shares during the last quarter. 83.99% of the stock is currently owned by institutional investors.
Shares of NASDAQ:CME opened at $187.33 on Wednesday. The firm has a market capitalization of $64.49 billion, a P/E ratio of 39.27, a price-to-earnings-growth ratio of 2.21 and a beta of 0.49. CME Group Inc has a 1 year low of $138.93 and a 1 year high of $190.43. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.09.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 27th. Investors of record on Monday, December 10th will be issued a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date of this dividend is Friday, December 7th. CME Group’s dividend payout ratio is presently 58.70%.
In other CME Group news, Director Martin J. Gepsman sold 300 shares of the company’s stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $172.30, for a total transaction of $51,690.00. Following the completion of the sale, the director now directly owns 42,912 shares in the company, valued at $7,393,737.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Julie Holzrichter sold 3,353 shares of the company’s stock in a transaction dated Tuesday, November 6th. The shares were sold at an average price of $186.71, for a total transaction of $626,038.63. Following the sale, the chief operating officer now owns 45,627 shares of the company’s stock, valued at $8,519,017.17. The disclosure for this sale can be found here. Insiders sold 23,572 shares of company stock valued at $4,206,309 over the last quarter. 0.43% of the stock is currently owned by corporate insiders.
A number of research firms have recently weighed in on CME. Wells Fargo & Co upped their price target on shares of CME Group from $175.00 to $177.00 and gave the stock a “market perform” rating in a research note on Friday, October 26th. Bank of America reaffirmed a “buy” rating and issued a $200.00 price target on shares of CME Group in a research note on Monday, November 5th. BidaskClub raised shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, October 9th. Berenberg Bank set a $184.00 price objective on shares of CME Group and gave the stock a “hold” rating in a report on Thursday, September 20th. Finally, Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating in a report on Wednesday, October 3rd. Five analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $182.69.
TRADEMARK VIOLATION NOTICE: “CME Group Inc (CME) Holdings Increased by Archon Partners LLC” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://www.thecerbatgem.com/2018/11/14/cme-group-inc-cme-holdings-increased-by-archon-partners-llc.html.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.